SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 43 filers reported holding APREA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$91,000
-35.5%
49,1000.0%0.00%
-50.0%
Q4 2021$141,000
-43.8%
49,1000.0%0.00%
-20.0%
Q3 2021$251,000
-57.4%
49,100
+100.4%
0.01%
-72.2%
Q3 2020$589,000
+18.8%
24,500
+91.4%
0.02%
-25.0%
Q2 2020$496,00012,8000.02%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders